Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ficus septica sap for cutaneous ulcers
NCT04453124Phase 2Completed
- Start
- Nov 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ficus septica exudate in yaws and Cutaneous ulcer. Primary endpoint: Number of participants with Clinical Healing at 21 days. Started Nov 2019; status: completed.
02
Drugs
ficus septica exudate
03
Conditions
yawsCutaneous ulcer
Beyond the preview
Go deeper on NCT04453124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04453124.